美國

證券交易委員會

華盛頓，特區。20549

表格8-K

當前報告

根據《1934年證券交易法》第13條或15(d)條的規定

《1934年證券交易法》

日期 報告內容（最早報告事件的日期）： 十一月 2024 年 1 月 1 日

FINNOVATE收購CORP。

（公司章程中指定的準確公司名稱）

+1 424-253-0908

根據交易所法規（17 CFR 240.14a-12）第14a-12規定的招股材料

不適用

(如自上次報告以來地址或名稱有變化，填上舊稱或舊地址)

如果本表8-K的提交同時滿足申報人根據下列規定的任何一個申報義務，請在下面適當的方框中打「X」:

根據《證券交易所法》第12(b) 章註冊的證券:

在勾選標記旁邊註明發行人是否是根據1933年證券法規則405條（本章節的§230.405）或1934年證券交易法規則12億.2條（本章節§2401.2億.2）定義的新興成長公司

新興成長型企業 ☒

如果是新興成長公司，請勾選，如果註冊人已選擇不使用根據交易所法案第13(a)條提供的任何新的或修改的財務會計準則的延長過渡期，請勾選。 ☐

基於與納斯達克股票市場有限責任公司（「納斯達克」）、Delaware公司SEP Acquisition Corp.（「公司」）和內布拉斯加州公司SANUWAVE Health, Inc.（「SANUWAVE」）的討論，認爲聯合公司不可能滿足納斯達克的上市要求，並撤回其上市申請，以提交申請給cboe BZX Exchange, Inc. 這個申請目前正在審核中。

股東特別會議延期

2024年11月1日，Finnovate Acquisition Corporation（「Finnovate」或「公司」）發佈了一份新聞稿（“新聞發佈”），宣佈由公司召集的股東特別大會（“特別會議”），原定於2024年11月1日東部時間上午10點舉行的會議將推遲至2024年11月6日東部時間上午10時舉行。 在特別會議上，股東將被要求考慮並批准將公司初次業務組合的時間考慮和批准的延期（“延長提案”）從2024年11月8日延長至2025年5月8日，或公司董事會（“擴展”),

經此變更，特別股東大會將於2024年11月6日上午10點（東部時間）通過直播網絡會議進行。https://www.cstproxy.com/finnovateacquisition/egm2024另外，由於此變更，公司首次公開發行的A類普通股（即「公衆股」）持有人提交股份以獲得有關展期的贖回權的截止日期將延長至2024年11月4日週一下午5點（東部時間）。任何曾經提交股份以贖回的股東，現在決定不贖回其股份，可在特別股東大會之前隨時撤回贖回申請，並經公司同意後可在大會後撤回。如果您已經將股份送交託管代理以便贖回，並在特別股東大會（現定於2024年11月6日上午10點（東部時間））投票前決定不贖回您的公衆股份，您可以要求託管代理將股份退還（實物或電子形式）。您可以通過以下方式聯繫託管代理發出此要求：

康地股份轉讓信託有限公司

to attend the virtual Shareholder Meeting starting            , 2024 at a.m., Eastern Time (two business days prior to the meeting date). Enter the URL address into your browser ^th樓層

（主要執行辦公室的地址，包括郵政編碼）

Attn: SPAC贖回團隊

電子郵件：spacredemptions@continentalstock.com

公司計劃在特別會議前期繼續向股東征求委託代理。只有截至2024年10月2日營業結束時持有公司普通股的股東，才有資格在特別會議上投票。

額外 向信託帳戶的現金捐款

公司還宣佈在新聞稿中提到，Finnovate贊助商LP（“贊助商”）或其指定人同意，在延期提案獲得批准並實施後，修改他們先前打算做出的貢獻。

贊助商之前已同意每個日曆月（從2024年11月8日開始，直到2025年5月8日結束）爲每個日曆月捐款37,500美元（該金額稱爲「月度金額」），直到2025年5月8日結束，或公司需要完成初始業務組合的每個月（統稱爲“延期 時期），或其部分，公司需要完成初始業務組合。

經修訂，贊助商及其指定人員現已同意爲每個未贖回的公衆股（「修訂月金額」）貢獻相等於0.05美元的金額，每次延期期間（“貢獻”）。 因此，在特別股東大會上，用於初次業務組合或公司清算的每股贖回金額將取決於完成初次業務組合所需的時間，而不是特別股東大會中贖回後仍未償還的公衆股的數量。例如，如果公司需要到2025年5月8日才能完成初次業務組合，即六個月的日曆月，贊助商或其指定人員將進行累計貢獻，導致每股未贖回股份的贖回金額約爲11.91美元，與當前每股約11.61美元的贖回金額進行對比。

Each Contribution will be deposited in the Company’s trust account within seven days from the beginning of each Extension Period (or portion thereof), and any Contribution is conditioned upon the implementation of the Extension. No Contribution will occur if the Extension is not approved or is not completed. The amount of each Contribution will not bear interest and will be repayable by the Company to the Sponsor or its designees upon consummation of its initial business combination. The Company will have the sole discretion whether to continue extending for additional calendar months until May 8, 2025. If the Company opts not to utilize any remaining portion of the Extension Period, then the Company will liquidate and dissolve promptly in accordance with its amended and restated memorandum and articles of association, as amended (the “Articles”), and its Sponsor’s obligation to make additional contributions will terminate. The Company will announce each Contribution, on a monthly basis, in a Current Report on Form 8-K, as each Contribution is deposited. All funds in the Company’s trust account, including those funds deposited in connection with the Contribution, will be held in an interest-bearing demand deposit account at a bank until the earlier of the consummation of the Company’s initial business combination or liquidation.

Listing Status

As previously disclosed in the Proxy Statement (as defined below) for the Special Meeting, the Company received written notice from Nasdaq indicating that the Nasdaq Hearings Panel had granted the Company’s request for continued listing on Nasdaq, subject to the Company completing a business combination with an operating entity and evidencing compliance with the criteria for initial listing on Nasdaq, by November 4, 2024. The Company does not expect that will be able to consummate its initial business combination prior by November 4, 2024. If Nasdaq completes the delisting of the Company’s securities from its exchange and the Company is not able to list its securities on another national securities exchange, the Company intends to maintain the ability for its securities to be quoted on the OTC Markets until the consummation of the Company’s initial business combination or earlier liquidation. For more information, see the risk factors in the Proxy Statement entitled “We have received several notices from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that we were not in compliance with two Nasdaq Listing Rules. If we cannot regain compliance, our securities will be subject to delisting, and the liquidity and the trading price of our securities could be adversely affected” and “Even if the Articles Extension Proposal is approved by our shareholders, our securities will be suspended from trading on Nasdaq and delisted if we do not consummate our initial business combination by November 3, 2024. Any trading suspension or delisting may have a material adverse effect on the trading of our securities and our ability to consummate an initial business combination.”

Forward-Looking Statements

This Current Report on Form 8-K (the “Report”) includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. These forward-looking statements and factors that may cause such differences include, without limitation, uncertainties relating to the Company’s shareholder approval of the Extension, its inability to complete an initial business combination within the required time period or, and other risks and uncertainties indicated from time to time in filings with the Securities and Exchange Commission (the “SEC”), including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 under the heading “Risk Factors” and in other reports the Company has filed, or to be filed, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Participants in the Solicitation

The Company and its directors, executive officers, other members of management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies from the securityholders of the Company in favor of the approval of the Extension Proposal. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of the Company’s directors and officers in the Company’s definitive proxy statement filed with the SEC on October 15, 2024 (as may be amended, the “Proxy Statement”), which may be obtained free of charge from the sources indicated above.

No Offer or Solicitation

This Report shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Extension. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

Additional Information and Where to Find It

The Company urges investors, shareholders and other interested persons to read the Proxy Statement as well as other documents filed by the Company with the SEC, because these documents will contain important information about the Company and the Extension. Shareholders may obtain copies of the Proxy Statement, without charge, at the SEC’s website at www.sec.gov or by directing a request to: Advantage Proxy, Inc., P.O. Box 10904, Yakima, WA 98909, Attn: Karen Smith.

The following exhibit is filed herewith:

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.